The Latest Cardiac and Vascular News
Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success DUBLIN and BARCELONA, Spain, Aug. 28, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its investigational EV ICD™ System – a first-of-its-kind defibrillator with the lead […]
Data from the ETNA-AF-Europe Registry provide insights on edoxaban in routine clinical practice in patient subpopulations including those who are frail, with heart failure or insulin-dependent diabetes1,2,3 Latest findings presented at the European Society of Cardiology (ESC) Congress 2022 add to the wealth of edoxaban data reinforcing its safety and […]
The OCEANIC program will start with two Phase III studies investigating the efficacy and safety of asundexian in the prevention of stroke events in patients with atrial fibrillation as well as patients with a non-cardioembolic ischemic stroke or high-risk transient ischemic attack1,2 OCEANIC-AF and OCEANIC-STROKE are expected to enroll up […]
Revolutionary trial design incorporates wearable sensors, FDA-cleared biomarkers and near real-time data to screen, enroll and track patients more quickly. The physIQ platform will support efficacy and safety evaluation of orally inhaled AF treatment which could mean more rapid restoration of normal sinus rhythm and symptom relief. CHICAGO–(BUSINESS WIRE)–A leader in […]
Leading Medical Center of Excellence adds second PURE EP™ System for evaluation, broadening physician access to the Company’s signal processing technology PURE EP™ is now being evaluated at both Main and Fairview campuses of Cleveland Clinic’s Heart, Vascular & Thoracic Institute BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), […]
WALTHAM, Mass.–(BUSINESS WIRE)–Thermedical®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today that the U.S. Food & Drug Administration (FDA) has approved an open-label, single-arm interventional clinical trial to evaluate the safety and efficacy of the Thermedical® SERF Ablation System with the Durablate® Catheter in people with ventricular tachycardia (VT) resistant to […]
The Caregility Cloud™ and Eko Connect integration addresses virtual care gaps by providing a more comprehensive physical exam experience to care teams and patients EATONTOWN, N.J. and OAKLAND, Calif., Aug. 18, 2022 /PRNewswire/ — Caregility, an enterprise telehealth platform company, and Eko, the market leader in stethoscopes for telehealth, today announced an integration partnership. Caregility’s cloud platform […]
First Annual HRX Meeting to Assemble Cardiovascular Innovators Focused on Transforming Patient Care TAMPA, Fla., Aug. 17, 2022 /PRNewswire/ — PaceMate, one of the nation’s fastest-growing cardiac rhythm management and remote patient monitoring companies, announced two of its co-founders have been chosen to speak at HRX 2022, the Heart Rhythm Society’s cardiovascular […]
Submission Seeks Approval for the Company’s Proprietary ECG Technology to Aid in Diagnosis of Heart Attack in $500 million Total Addressable Market 18+ million People in the US have Coronary Artery Disease and Heart Attacks Occur Every 40 Seconds SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital […]
Medicalgorithmics has received FDA approval in the U.S. for its proprietary next generation system in ECG signal analysis called DeepRhytmAI. WARSAW, Poland, Aug. 10, 2022 /PRNewswire/ — It is a cloud-based Artificial Intelligence algorithm that classifies ECG signals. Without excessive human involvement, DeepRhytmAI is able to recognize a wide range of arrhythmia disorders […]
